Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02600832 · ClinicalTrials.gov registry record · NA

AABM to Decrease Problem Drinking and Impulsivity in Veterans With AUD: A Pilot Study

A NA study, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
32
Enrollment target

NCT02600832 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 32 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02600832, a NA study, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target

Study Summary

The proposed study is a pilot prospective, parallel groups, randomized, double blind, sham training-controlled, 9-session (over 3 weeks) clinical trial of AABM in 32 male and female veterans entering treatment for AUD at the VA Medical Center at San Francisco, California, between ages 18-65. The study consists of screening, 3-week AABM training, Week-4 post-test, and Week-12 follow-up. Assessment of inhibitory control, alcohol approach bias and craving will be administered at baseline and Week-4. Immediately following screening, patients will be randomly assigned to receive 9 sessions of real or sham AABM training (16 subjects each) taking place over three weeks. Following the 3 weeks of training, patients will complete a Week-4 post-test which includes assessment of alcohol approach bias, inhibitory control, and craving and a Week-12 follow-up assessing drinking behavior.

Interventions

  • BEHAVIORAL Sham Training
  • BEHAVIORAL AABM Training

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2016-01
Est. Completion 2018-02-07
Phase NA

What the Registry Record Tells You About NCT02600832

The ClinicalTrials.gov registry entry for NCT02600832 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Sham Training is the first listed.

NCT02600832 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02600832 about?

NCT02600832 is a clinical study titled "AABM to Decrease Problem Drinking and Impulsivity in Veterans With AUD: A Pilot Study". The proposed study is a pilot prospective, parallel groups, randomized, double blind, sham training-controlled, 9-session (over 3 weeks) clinical trial of AABM in 32 male and female veterans entering treatment for AUD at the VA Medical Center at San Francisco, California, between ages 18-65. The stu...

What is the current status of trial NCT02600832?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2016-01. Estimated completion is 2018-02-07.

What interventions are being tested in trial NCT02600832?

The interventions under investigation include: Sham Training (BEHAVIORAL), AABM Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT02600832?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.